Xenetic Biosciences, Inc. (XBIO) Sof foyda bo'yicha sotuv rentabelligi

XBIO (xeneticbio.com) - kompaniyaning tovar belgisi

Xenetic Biosciences (XBIO) robotlashtirilgan kichik molekulali skrining orqali onkologik dori vositalarini yaratishni avtomatlashtiradi. Sof foyda marjasi boshqaruv samaradorligini ko'rsatadi, bunda -123.70 belgisi eng so'nggi ma'lumotlarni aks ettiradi. Davolashga bo'lgan talab doimiy bo'lgani sababli, aktiv makroiqtisodiy tendentsiyalardan mustaqil qolmoqda. Hozirgi vaqtda Xenetic Biosciences tadqiqot va ishlanmalarga (R&D) e'tibor qaratgan holda, B-hujayrali limfoma terapiyasi uchun XCART platformasini ishlab chiqmoqda.

xeneticbio.com (XBIO) - Kompaniya sotuv marjasi 04.07.2022dan 20.11.2026gacha

xeneticbio.com (XBIO) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya kursi va ekspertlarning narx prognozi:
Xenetic Biosciences tayyor mahsulotlari

Defensiv portfel daromadning har bir dollari uchun sof qoldiqni yaratish bo'yicha aktivning qobiliyatini qat'iy tekshirishni talab qiladi. Ushbu metrika umumiy aylanma ichidagi yakuniy foyda ulushini o'lchab, biznesning haqiqiy xavfsizlik zaxirasini belgilaydi. DNase ning preklinik tadqiqotlar bosqichida bo'lgan Xenetic Biosciences (XBIO) uchun ushbu metrika R&D xarajatlarini boshqarish samaradorligini aks ettiradi. Sof aylanma rentabelligidagi tendentsiya kompaniyaning laboratoriya sikli doirasidagi moliyaviy barqarorligini baholash imkonini beradi.

Xenetic Biosciences (XBIO) raqobatchilari

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|YMAB: Sotuvning sof marjinal rentabelligi|AURA - Kompaniya sotuv marjasi|CADL (Candel Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi ARAY (Accuray)|Sof foyda bo'yicha sotuv rentabelligi SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Sof marja|Sof marja Citius Oncology, Inc. CTOR|HURA - Sof foyda bo'yicha sotuv rentabelligi|protaratx.com - Sotuvning sof marjinal rentabelligi|FATE - Sotuvning sof marjinal rentabelligi|WHWK: Sotuvning sof marjinal rentabelligi|TScan Therapeutics (TCRX) - Sotuvning sof marjinal rentabelligi|Sof marja Champions Oncology|Sof marja XBIT|Sotuvning sof marjinal rentabelligi CVM|Sof foyda bo'yicha sotuv rentabelligi OS Therapies Inc. OSTX|Sof marja Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Sof marja|ANL - Sof marja|Sof marja verupharma.com|TPST: Sotuvning sof marjinal rentabelligi|XLO - Kompaniya sotuv marjasi|Sof marja Renovaro|Sotuvning sof marjinal rentabelligi muraloncology.com|Sotuvning sof marjinal rentabelligi KAPA|Kompaniya sotuv marjasi OnKure Therapeutics, Inc.|Sotuvning sof marjinal rentabelligi GDTC (w2.cytomed.sg)|CRIS - Sof foyda bo'yicha sotuv rentabelligi|Apollomics - Sotuvning sof marjinal rentabelligi|Tharimmune Corp (THAR) - Sof foyda bo'yicha sotuv rentabelligi|ADVB: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi SBFM (Sunshine Biopharma)|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)